Peptide Anchor for Folate-Targeted Liposomal Delivery

Area of Science:

• Nanotechnology
• Biomedical Engineering
• Drug Delivery Systems

Background:

• Specific folate receptors are overexpressed on macrophages and cancer cells, making them targets for drug delivery.
• Current folate-targeted liposomes often use long polyethylene glycol (PEG) spacers, which can be inefficient.
• Folate receptor targeting is crucial for delivering therapeutics to cancer cells and activated macrophages.

Purpose of the Study:

• To develop and evaluate an innovative liposome delivery system for targeted folate receptor delivery.
• To compare the efficiency of a novel folate-liposome conjugate with a traditional PEG-based system.
• To assess the stability and specificity of the new targeting strategy.

Main Methods:

• A novel strategy was employed using a hydrophobic fragment of surfactant protein D linked to folate via a short, 4 amino acid peptide spacer.
• The peptide conjugate was designed to insert into the liposome bilayer, maintaining integrity.
• Liposomes encapsulated the nuclear dye Hoechst 34580 to quantify delivery efficiency upon DNA binding after liposome disruption.

Main Results:

• The novel folate-linked peptide conjugate demonstrated high stability and specificity within the liposomal bilayer.
• The new system showed a 2-fold greater efficiency in delivering the encapsulated dye into Caco-2 cells compared to traditional PEG-linked systems.
• The hydrophobic peptide linker facilitated deep insertion into the lipid bilayer without compromising liposomal integrity.

Conclusions:

• The novel folate-targeting strategy using a short peptide linker represents a significant advancement in liposome-based drug delivery.
• This approach offers enhanced efficiency and stability for targeting folate receptors on cancer cells.
• The findings suggest potential for improved therapeutic outcomes in folate receptor-targeted cancer therapies.